BioNTech and Pfizer Settle Vaccine Royalty Disputes
BioNTech and Pfizer resolve COVID-19 vaccine royalty disputes with NIH and UPenn, ensuring smooth collaboration.
BioNTech, in partnership with Pfizer, has settled royalty disputes involving their COVID-19 vaccine.